London · Delayed Price · Currency is GBP · Price in GBX Cardiogeni Statistics
Total Valuation
Cardiogeni has a market cap or net worth of GBP 6.73 million. The enterprise value is 6.64 million.
| Market Cap | 6.73M |
| Enterprise Value | 6.64M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Cardiogeni has 96.15 million shares outstanding.
| Current Share Class | 96.15M |
| Shares Outstanding | 96.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 60.21% |
| Owned by Institutions (%) | n/a |
| Float | 38.26M |
Valuation Ratios
The trailing PE ratio is 6.14.
| PE Ratio | 6.14 |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 8.08 |
| P/TBV Ratio | 29.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.06 |
| EV / Sales | 0.85 |
| EV / EBITDA | 2.13 |
| EV / EBIT | 2.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74
| Current Ratio | 0.74 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 116.98% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 344.44% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.60M |
| Profits Per Employee | 365,586 |
| Employee Count | 3 |
| Asset Turnover | 4.83 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.22% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.22% |
| 50-Day Moving Average | 7.00 |
| 200-Day Moving Average | 7.18 |
| Relative Strength Index (RSI) | 0.42 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cardiogeni had revenue of GBP 7.79 million and earned 1.10 million in profits.
| Revenue | 7.79M |
| Gross Profit | 7.79M |
| Operating Income | 3.02M |
| Pretax Income | 1.10M |
| Net Income | 1.10M |
| EBITDA | 3.12M |
| EBIT | 3.02M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 84,759 in cash and no debt, with a net cash position of 84,759 or 0.00 per share.
| Cash & Cash Equivalents | 84,759 |
| Total Debt | n/a |
| Net Cash | 84,759 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 833,336 |
| Book Value Per Share | n/a |
| Working Capital | -154,957 |
Cash Flow
| Operating Cash Flow | -3.03M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 96,803 |
| Net Borrowing | -80,002 |
| Free Cash Flow | -3.03M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 100.00%, with operating and profit margins of 38.73% and 14.07%.
| Gross Margin | 100.00% |
| Operating Margin | 38.73% |
| Pretax Margin | 14.06% |
| Profit Margin | 14.07% |
| EBITDA Margin | 39.98% |
| EBIT Margin | 38.73% |
| FCF Margin | n/a |
Dividends & Yields
Cardiogeni does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 16.29% |
| FCF Yield | -44.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardiogeni has an Altman Z-Score of 6.3 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.3 |
| Piotroski F-Score | 4 |